<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2021-21-2-26-34</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-6631</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Психиатрия</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Psychiatry</subject></subj-group></article-categories><title-group><article-title>Интеллектуальное снижение у больных шизофренией с коморбидными сахарным диабетом II типа и алкоголизмом</article-title><trans-title-group xml:lang="en"><trans-title>Intellectual decline in patients with schizophrenia with comorbid type ii diabetes mellitus and alcoholism</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4320-3644</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Костюк</surname><given-names>Г. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kostyuk</surname><given-names>G. Р.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Костюк Георгий Петрович – доктор медицинских наук, профессор, главный внештатный специалист-психиатр ДЗ г. Москвы; главный врач, ПКБ №1 им. Н.А. Алексеева.</p><p>117152, Москва, Загородное шоссе, д. 2.</p></bio><bio xml:lang="en"><p>Georgy Р. Kostyuk - Dr. Sci. (Med.), Professor, Chief External Psychiatrist of Moscow Healthcare Department, Chief Medical Officer, Alekseev Psychiatric Clinical Hospital No. 1.</p><p>2, Zagorodnoye Shosse, Moscow, 117152.</p></bio><email xlink:type="simple">pkb1@zdrav.mos.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6489-9623</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черепахин</surname><given-names>Д. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Cherepakhin</surname><given-names>D. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Черепахин Дмитрий Игоревич - врач-психиатр.</p><p>117152, Москва, Загородное шоссе, д. 2.</p></bio><bio xml:lang="en"><p>Dmitriy I. Cherepakhin - Psychiatrist, Alekseev Psychiatric Clinical Hospital No. 1.</p><p>2, Zagorodnoye Shosse, Moscow, 117152.</p></bio><email xlink:type="simple">dimadimacher@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6881-1641</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аронов</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Aronov</surname><given-names>P. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аронов Павел Владимирович – кандидат медицинских наук доцент кафедры психиатрии, наркологии и психотерапии, Академия постдипломного образования.</p><p>115682, Москва, Ореховый бульвар, д. 28.</p></bio><bio xml:lang="en"><p>Pavel V. Aronov - Cand. Sci. (Med.), Associate Professor of Department of Psychiatry, Narcology and Psychotherapy, Academy of Postgraduate Education, Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies.</p><p>28, Orekhovyy Boulevard, Moscow, 115682.</p></bio><email xlink:type="simple">info@fnkc-fmba.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9831-8970</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бельская</surname><given-names>Г. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Belskaya</surname><given-names>G. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бельская Галина Николаевна - доктор медицинских наук, профессор, заведующая Многопрофильным клинико-диагностическим центром.</p><p>125367, Москва, Волоколамское шоссе, д. 80.</p></bio><bio xml:lang="en"><p>Galina N. Belskaya - Dr. Sci. (Med.), Professor, Head of Multispecialty Clinical Diagnostic Center, Research Center of Neurology.</p><p>80, Volokolamskoe Shosse, Moscow, 125367.</p></bio><email xlink:type="simple">belskaya@neurology.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4991-663X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никифоров</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikiforov</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никифоров Игорь Анатольевич - доктор медицинских наук, профессор, заведующий кафедрой психиатрии, наркологии и психотерапии, Академия постдипломного образования.</p><p>115682, Москва, Ореховый бульвар, д. 28.</p></bio><bio xml:lang="en"><p>Igor A. Nikiforov - Dr. Sci. (Med.), Professor, Head of Department of Psychiatry, Narcology and Psychotherapy, Academy of Postgraduate Education, Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies.</p><p>28, Orekhovyy Boulevard, Moscow, 115682.</p></bio><email xlink:type="simple">narkolog.ipk@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Психиатрическая клиническая больница №1 имени Н.А. Алексеева</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Alekseev Psychiatric Clinical Hospital No. 1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Научный центр неврологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Center of Neurology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>08</day><month>01</month><year>2022</year></pub-date><volume>0</volume><issue>21-2</issue><fpage>26</fpage><lpage>34</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Костюк Г.П., Черепахин Д.И., Аронов П.В., Бельская Г.Н., Никифоров И.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Костюк Г.П., Черепахин Д.И., Аронов П.В., Бельская Г.Н., Никифоров И.А.</copyright-holder><copyright-holder xml:lang="en">Kostyuk G.Р., Cherepakhin D.I., Aronov P.V., Belskaya G.N., Nikiforov I.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/6631">https://www.med-sovet.pro/jour/article/view/6631</self-uri><abstract><p>Коморбидные состояния в общей психопатологической практике в равной степени нуждаются в исследованиях как в области психиатрии и наркологии, так и в разработке вопросов социальной практики в отношении психических больных. Существует мнение о том, что коморбидные психические патологии встречаются даже чаще, чем «чистые» формы заболеваний. В большинстве случаев коморбидных состояний медицинское сообщество все чаще встречает клинические ситуации, где «классические» симптомы и синдромы деформируются, взаимно переплетаются и, накладываясь на актуальную социальную ситуацию пациента, приобретают «нереальный причудливый характер». Шизофрения на этапе становления современной психиатрии остается одной из наиболее актуальных ее проблем. На сегодняшний день в общей популяции больных насчитывается 1,1% мужчин и 1,9% женщин. Расстройства шизофренического спектра часто сочетаются с рядом хронических патологий, которые усиливают негативное влияние на нейро-когнитивную сферу человека. Одними из главных проблем современного урбанизированного общества являются сахарный диабет II типа и алкоголизм. Усиливая негативное влияние на когнитивные способности человека, они ускоряют процесс распада личности и его социального функционирования. Интеллектуальный уровень пациентов с теми хроническими заболеваниями, которые требуют от больных активного и осознанного участия в процессе лечения и социального функционирования, способен в значительной степени повлиять на способность больного к обучению, самостоятельному ведению заболевания, установления высокого уровня комплаенса и, как следствие, на эффективность проводимой терапии. Внимательное изучение состояния интеллекта пациентов с коморбидной патологией приведет к улучшению социальной адаптации пациента, более внимательному отношению к своему соматическому здоровью и уменьшит риск инвалидизации трудоспособного населения.</p></abstract><trans-abstract xml:lang="en"><p>Comorbid conditions in general psychopathological practice need equally research in the field of psychiatry and narcology, as well as the development of issues of social practice in relation to mental patients. There is an opinion that comorbid mental pathologies are even more common than “pure” forms of diseases. In most cases of comorbid conditions, the medical community increasingly encounters clinical situations where “classic” symptoms and syndromes are deformed, mutually intertwined and, superimposed on the actual social situation of the patient, acquire an “unreal fancy character”.</p><p>Schizophrenia remains one of the most urgent problems at the stage of modern psychiatry formation. Up to date there are 1.1% of men and 1.9% of women in the general population of patients. Schizophrenic spectrum disorders are often combined with a number of chronic pathologies that increase the negative impact on the neuro-cognitive sphere of a person. One of the main problems of modern urbanized society is type II diabetes and alcoholism. By increasing the negative impact on a person’s cognitive abilities, they accelerate the process of disintegration of personality and its social functioning. The intellectual level of patients with those chronic diseases that require patients to actively and consciously participate in the treatment process and social functioning can significantly affect the patient’s ability to learn, independently manage the disease, establish a high level of compliance and, as a result, the effectiveness of therapy. An attentive study of the issue of the state of intelligence of patients with comorbid pathology will lead to an improvement in the patient’s social adaptation, a more careful attitude to their somatic health and reduce the risk of disability of the able-bodied population.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>коморбидность</kwd><kwd>шизофрения</kwd><kwd>сахарный диабет II типа</kwd><kwd>алкоголизм</kwd><kwd>интеллект</kwd></kwd-group><kwd-group xml:lang="en"><kwd>comorbidity</kwd><kwd>schizophrenia</kwd><kwd>type II diabetes</kwd><kwd>alcoholism</kwd><kwd>mentality</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бохан Н.А., Семке В.Я. Коморбидность в наркологии. Томск: Издательство Томского университета; 2009. 522 с. Режим доступа: http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000395136.</mixed-citation><mixed-citation xml:lang="en">Bohan N.A., Semke V.Ya. Comorbidity in narcology. Tomsk: Tomsk University Press; 2009. 522 p. (In Russ.) Available at: http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000395136.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hubbard J.R., Martin P.R. Substance Abuse in the Mentally and Physically Disabled. 1st ed. Florida: CRC Press; 2001. 326 p. https://doi.org/10.1201/b14027.</mixed-citation><mixed-citation xml:lang="en">Hubbard J.R., Martin P.R. Substance Abuse in the Mentally and Physically Disabled. 1st ed. Florida: CRC Press; 2001. 326 p. https://doi.org/10.1201/b14027.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Чернобровкина Т.В., Артемчук А.Ф., Сосин И.К., Никифоров И.А. Проблема коморбидности и современные формы алкогольной болезни (клинико-патогенетический аспект). Наркология. 2006;5(12):47–74. Режим доступа: https://elibrary.ru/item.asp?id=27811548.</mixed-citation><mixed-citation xml:lang="en">Chernobrovkina T.V., Artemchuk A.F., Sosin I.K., Nikiforov I.A. The problem of comorbidity and modern forms of alcoholic illness (clinical and pathogenetic aspect). Narkologiya = Narcology. 2006;5(12):47–74. (In Russ.) Available at: https://elibrary.ru/item.asp?id=27811548.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Andrews G., Henderson S., Hall W. Prevalence, comorbidity, disability and service utilization. Overview of the Australian National Mental Health Survey. Br J Psychiatry. 2001;178(2):145–153. https://doi.org/10.1192/bjp.178.2.145.</mixed-citation><mixed-citation xml:lang="en">Andrews G., Henderson S., Hall W. Prevalence, comorbidity, disability and service utilization. Overview of the Australian National Mental Health Survey. Br J Psychiatry. 2001;178(2):145–153. https://doi.org/10.1192/bjp.178.2.145.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ball J.C., Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. New York: Springer-Verlag; 1991. 283 p. Available at: https://link.springer.com/book/10.1007/978-1-4613-9089-3.</mixed-citation><mixed-citation xml:lang="en">Ball J.C., Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. New York: Springer-Verlag; 1991. 283 p. Available at: https://link.springer.com/book/10.1007/978-1-4613-9089-3.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Crawford V., Clancy C., Crome I. B. Co-existing problems of mental health and substance misuse (dual diagnosis): a literature review. Drugs: Educ Prev Policy. 2003;10(1):1–74. https://doi.org/10.1080/0968763031000072990.</mixed-citation><mixed-citation xml:lang="en">Crawford V., Clancy C., Crome I. B. Co-existing problems of mental health and substance misuse (dual diagnosis): a literature review. Drugs: Educ Prev Policy. 2003;10(1):1–74. https://doi.org/10.1080/0968763031000072990.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kertesz S.G., Madan A., Wallace D., Schumacher J.E., Milby J.B. Substance abuse treatment and psychiatric comorbidity: do benefits spill over? Analysis of data from a prospective trial among cocainedependent homeless persons. Subst Abuse Treat Prev Policy. 2006;1:27. https://doi.org/10.1186/1747-597X-1-27.</mixed-citation><mixed-citation xml:lang="en">Kertesz S.G., Madan A., Wallace D., Schumacher J.E., Milby J.B. Substance abuse treatment and psychiatric comorbidity: do benefits spill over? Analysis of data from a prospective trial among cocainedependent homeless persons. Subst Abuse Treat Prev Policy. 2006;1:27. https://doi.org/10.1186/1747-597X-1-27.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Снежневский А.В. О течении и нозологическом единстве шизофрении (методика и результаты исследования). Вестник АМН СССР. 1966;(3):3–10.</mixed-citation><mixed-citation xml:lang="en">Snezhnevsky A.V. On the course and nosological unity of schizophrenia (methodology and research results). Vestnik akademii meditsinskikh nauk USSR = Bulletin of the USSR Academy of Medical Sciences. 1966;(3):3–10. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Снежневский А.В. Шизофрения: клиника и патогенез. М.: Медицина; 1969.</mixed-citation><mixed-citation xml:lang="en">Snezhnevsky A.V. Schizophrenia: clinic and pathogenesis. Moscow: Medicine; 1969. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Снежневский А.В. (ред.). Шизофрения: мультидисциплинарное исследование. М.: Медицина; 1972. 403 с. Режим доступа: https://www.rlsnet.ru/library/books/pogranichnaya-psixiatriya/nosos-et-pathos-schizophreniae-snezhnevskij-a.-v.</mixed-citation><mixed-citation xml:lang="en">Snezhnevsky A.V. (ed.). Schizophrenia: a multidisciplinary study. Moscow: Medicine; 1972. 403 p. (In Russ.) Available at: https://www.rlsnet.ru/library/books/pogranichnaya-psixiatriya/nosos-et-pathos-schizophreniae-snezhnevskij-a.-v.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bleuler E. Die Prognose der Dementia praecox. Allgemeine Zeitung Psychiatrie. 1908;Bd. 65:436–464.</mixed-citation><mixed-citation xml:lang="en">Bleuler E. Prognosis of dementia praecox. General newspaper psychiatry. 1908;Bd. 65:436–464.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Nixon S.J., Hallford H.G., Tivis R.D. Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients. Psychiatry Res. 1996;64(1):35–45. https://doi.org/10.1016/0165-1781(96)02911-3.</mixed-citation><mixed-citation xml:lang="en">Nixon S.J., Hallford H.G., Tivis R.D. Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients. Psychiatry Res. 1996;64(1):35–45. https://doi.org/10.1016/0165-1781(96)02911-3.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Наджаров Р.А., Тиганов А.С., Смулевич А.Б., Шахматов Н.Ф., Иванов Вл., Морозов Г.В. (ред.). Шизофрения. М.: Медицина; 1988.</mixed-citation><mixed-citation xml:lang="en">Nadzharov R.A., Tiganov A.S., Smulevich A.B., Shakhmatov N.F., Ivanov V., Morozov G.V. (ed.). Schizophrenia. Moscow: Medicine; 1988. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Тиганов А.С. (ред.). Руководство по психиатрии. М.: Медицина; 1999. 784 с. Режим доступа: http://ncpz.ru/siteconst/userfiles/file/PDF/tiganov2.pdf.</mixed-citation><mixed-citation xml:lang="en">Tiganov A.S. (ed.). Handbook of Psychiatry. Moscow: Medicine; 1999. 784 p. (In Russ.) Available at: http://ncpz.ru/siteconst/userfiles/file/PDF/tiganov2.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Коркина М.В., Лакосина Н.Д., Личко А.Е., Сергеев И.И. Психиатрия: Учебник для студентов медицинских вузов. М.: Медпресс-информ; 2004. 576 с. Режим доступа: https://rykovodstvo.ru/exspl/49657/index.html?page=4.</mixed-citation><mixed-citation xml:lang="en">Korkina M.V., Lakosina N.D., Lichko A.E., Sergeev I.I. Psychiatry: Textbook for medical university students. Moscow: Medpress-inform; 2004. 576 p. (In Russ.) Available at: https://rykovodstvo.ru/exspl/49657/index.html?page=4.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Попов М.Ю. Теоретические предпосылки концептуализации шизофрении. Сообщение 1. Диагностическое значение фактора прогредиентности. Российский психиатрический журнал. 2004;(3):28–34. Режим доступа: https://www.sinref.ru/000_uchebniki/04500psihologia/000_lekcii_psihologia_10/230.htm.</mixed-citation><mixed-citation xml:lang="en">Popov M.Y. Theoretical prerequisites for the conceptualization of schizophrenia. Message 1. Diagnostic value of the progression factor. Rossiyskiy psikhiatricheskiy zhurnal = Russian Psychiatric Journal. 2004;(3):28–34. (In Russ.) Available at: https://www.sinref.ru/000_uchebniki/04500psihologia/000_lekcii_psihologia_10/230.htm.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Попов М.Ю. Теоретические предпосылки концептуализации шизофрении. Сообщение 2. Валидность категориального подхода (на примере современных классификаций). Российский психиатрический журнал. 2004;(4):18–24.</mixed-citation><mixed-citation xml:lang="en">Popov M.Y. Theoretical prerequisites for the conceptualization of schizophrenia. Message 2. Validity of the categorical approach (on the example of modern classifications). Rossiyskiy psikhiatricheskiy zhurnal = Russian Psychiatric Journal. 2004;(4):18–24. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bleuler E. Lehrbuch der Psychiatrie. New York–Berlin: Springer-Verlag; 1972. 704 p. Available at: https://archive.org/details/lehrbuchderpsy-c00bleugoog/page/n9/mode/2up.</mixed-citation><mixed-citation xml:lang="en">Bleuler E. Psychiatry textbook. New York–Berlin: Springer-Verlag; 1972. 704 p. (In Germ.) Available at: https://archive.org/details/lehrbuchderpsy-c00bleugoog/page/n9/mode/2up.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Cadoret R.J., King L.J. Psychiatry in primary care. Saint Louis: C.V. Mosby Company; 1974. 339 p. Available at: https://archive.org/details/psychiatry-inprim0000cado/page/n5/mode/2up.</mixed-citation><mixed-citation xml:lang="en">Cadoret R.J., King L.J. Psychiatry in primary care. Saint Louis: C.V. Mosby Company; 1974. 339 p. Available at: https://archive.org/details/psychiatry-inprim0000cado/page/n5/mode/2up.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Arieti S. (ed.) American handbook psychiatry. New York: Basic Book; 1974. 761 p. Available at: https://archive.org/details/americanhandbook00arie.</mixed-citation><mixed-citation xml:lang="en">Arieti S. (ed.) American handbook psychiatry. New York: Basic Book; 1974. 761 p. Available at: https://archive.org/details/americanhandbook00arie.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Straychorn J.M. Foundations of clinical psychiatry. London: Year Book Medical Publishers; 1982. 590 p. https://doi.org/10.1017/S0007125000113868.</mixed-citation><mixed-citation xml:lang="en">Straychorn J.M. Foundations of clinical psychiatry. London: Year Book Medical Publishers; 1982. 590 p. https://doi.org/10.1017/S0007125000113868.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ястребов В.С., Митихина И.А., Митихин В.Г., Шевченко Л.С., Солохина Т.А. Психическое здоровье населения мира: социально-экономический аспект (по данным зарубежных исследований 2000–2010 гг.). Журнал невролологии и психиатрии имени С.С. Корсакова. 2012;112(2):4–13. Режим доступа: https://elibrary.ru/item.asp?id=17911821.</mixed-citation><mixed-citation xml:lang="en">Yastrebov V.S., Mitikhina I.A., Mitikhin V.G., Shevchenko L.S., Solokhina T.А. Mental health of the world population: socio-economic aspect (according to foreign studies 2000–2010). Zhurnal nevrolologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(2):4–13. (In Russ.) Available at: https://elibrary.ru/item.asp?id=17911821.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ястребов В.С., Солохина Т.А., Шевченко Л.С., Митихин В.Г., Творогова Н.А., Харькова Т.Л. Экономическая оценка масштаба вложений и потерь вследствие психических заболеваний: методология исследования и социально-экономический прогноз последствий. Социальная и клиническая психиатрия. 2009;19(4):21–28. Режим доступа: https://elibrary.ru/item.asp?id=13022192.</mixed-citation><mixed-citation xml:lang="en">Yastrebov V.S., Solokhina T.A., Shevchenko L.S., Mitikhin V.G., Tvorogova N.A., Kharkova T.L. Economic assessment of the scale of investments and losses due to mental illness: research methodology and socio-economic forecasting of consequences. Sotsialnaya i klinicheskaya psikhiatriya = Social and Clinical Psychiatry. 2009;19(4):21–28. (In Russ.) Available at: https://elibrary.ru/item.asp?id=13022192.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ястребов В.С., Солохина Т.А., Шевченко Л.С., Творогова Н.А., Харькова Т.Л., Митихин В.Г. Экономическая оценка последствий психических заболеваний. М.: МАКС Пресс; 2009. 32 с. Режим доступа: http://ncpz.ru/lib/56/book/117/chapter/1.</mixed-citation><mixed-citation xml:lang="en">Yastrebov V.S., Solokhina T.A., Shevchenko L.S., Tvorogova N.A., Kharkova T.L., Mitikhin V.G. Economic assessment of the consequences of mental illness. Moscow: MAX Press; 2009. 32 p. (In Russ.) Available at: http://ncpz.ru/lib/56/book/117/chapter/1.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Гурович И.Я., Любов Е.Б., Чапурин С.А., Чурилин Ю.Ю., Еналиев И.Р. Бремя депрессивных расстройств в отечественных психиатрических службах. Журнал неврологии и психиатрии имени С.С. Корсакова. 2010;110(3):77–82. Режим доступа: https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2010/3/031997-72982010313.</mixed-citation><mixed-citation xml:lang="en">Gurovich I.Ya, Lyubov E.B., Chapurin S.A., Churilin Yu.Yu., Enaliev I.R. The burden of depressive disorders in Russian psychiatric services. Zhurnal nevrolologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(3):77–82. (In Russ.) Available at: https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2010/3/031997-72982010313.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Гурович И.Я., Любов Е.Б. Фармакоэпидемиология и фармакоэкономика в психиатрии. М.: Медпрактика-М; 2003. 263 с. Режим доступа: https://search.rsl.ru/ru/record/01002387295.</mixed-citation><mixed-citation xml:lang="en">Gurovich I.Ya., Lyubov E.B. Pharmacoepidemiology and pharmacoeconomics in psychiatry. Moscow: Medical Practice-M; 2003. 263 p. (In Russ.) Available at: https://search.rsl.ru/ru/record/01002387295.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Гурович И.Я., Шмуклер А.Б., Костюк Г.П., Нарышкин А.В. Контингент пациентов психиатрической больницы (по материалам однодневной переписи). Социальная и клиническая психиатрия. 2013;23(2):5–14. Режим доступа: https://psychiatr.ru/magazine/scp/30.</mixed-citation><mixed-citation xml:lang="en">Gurovich I.Ya., Shmukler A.B., Kostyuk G.P., Naryshkin A.V. Patient population of a psychiatric hospital (a case study of the one-day census). Sotsialnaya i klinicheskaya psikhiatriya = Social and Clinical Psychiatry. 2013;23(2):5–14. (In Russ.) Available at: https://psychiatr.ru/magazine/scp/30.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Гурович И.Я. Психиатрические больницы сегодня. Проблемы и перспективы развития стационарной психиатрической помощи. 2009;(1):37–45. Режим доступа: https://www.elibrary.ru/item.asp?id=42788510&amp;pff=1.</mixed-citation><mixed-citation xml:lang="en">Gurovich, I.Ya. Psychiatric hospitals today. Problemy i perspektivy razvitiya statsionarnoy psikhiatricheskoy pomoshchi = Problems and Prospects of Development of Inpatient Psychiatric Care. 2009;(1):37–46. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=42788510&amp;pff=1.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Кожинова Т.А. Особенности формирования и течения алкоголизма у лиц с акцентуациями характера и личностными расстройствами. Социальная и клиническая психиатрия. 2018;28(3):46–55. Режим доступа: https://elibrary.ru/item.asp?id=35546148.</mixed-citation><mixed-citation xml:lang="en">Kozhinova T.A. Features of the formation and course of alcoholism in persons with character accentuations and personality disorders. Sotsialnaya i klinicheskaya psikhiatriya = Social and Clinical Psychiatry. 2018;28(3):46–55. (In Russ.) Available at: https://elibrary.ru/item.asp?id=35546148.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Bernardin F., Maheut-Bosser A., Paille F. Cognitive impairment of alcoholdependent subjects. Rev Prat. 2014;64(4):462–465. https://doi.org/10.3389/fpsyt.2014.00078 .</mixed-citation><mixed-citation xml:lang="en">Bernardin F., Maheut-Bosser A., Paille F. Cognitive impairment of alcoholdependent subjects. Rev Prat. 2014;64(4):462–465. https://doi.org/10.3389/fpsyt.2014.00078.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Perry C.J. Cognitive Decline and Recovery in Alcohol Abuse. J Mol Neurosci. 2016;60(3):383–389. https://doi.org/10.1007/s12031-016-0798-4.</mixed-citation><mixed-citation xml:lang="en">Perry C.J. Cognitive Decline and Recovery in Alcohol Abuse. J Mol Neurosci. 2016;60(3):383–389. https://doi.org/10.1007/s12031-016-0798-4.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Mueser K.T., Drake R.E., Wallach M.A. Dual diagnosis: a review of etiological theories. Addict Behav. 1998;23(6):717–734. https://doi.org/10.1016/S0306-4603(98)00073-2.</mixed-citation><mixed-citation xml:lang="en">Mueser K.T., Drake R.E., Wallach M.A. Dual diagnosis: a review of etiological theories. Addict Behav. 1998;23(6):717–734. https://doi.org/10.1016/S0306-4603(98)00073-2.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Малков К.Д. Особенности динамики непрерывно текущей параноидной шизофрении, сочетанной с алкоголизмом. Вопросы наркологии. 2000;(3):44–50.</mixed-citation><mixed-citation xml:lang="en">Malkov K.D. Features of the dynamics of continuously ongoing paranoid schizophrenia combined with alcoholism. Voprosy narkologii = Addiction Issues. 2000;(3):44–50. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Шулькин Л.М. Oсобенности формирования и течения алкогольной зависимости у пациентов с параноидной шизофренией. Вопросы наркологии. 2008;(6):5–13. Режим доступа: https://www.elibrary.ru/item.asp?id=21406083.</mixed-citation><mixed-citation xml:lang="en">Shulkin L.M. features of the formation and course of alcohol dependence in patients with paranoid schizophrenia. Voprosy narkologii = Addiction Issues. 2008;(6):5–13. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=21406083.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Johnstone E.C., Ebmeier K.P., Miller P., Owens D.G.C., Lawrie S.M. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry. 2005;186:18–25. https://doi.org/10.1192/bjp.186.1.18.</mixed-citation><mixed-citation xml:lang="en">Johnstone E.C., Ebmeier K.P., Miller P., Owens D.G.C., Lawrie S.M. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry. 2005;186:18–25. https://doi.org/10.1192/bjp.186.1.18.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Ribbe K., Ackermann V., Schwitulla J., Begemann M., Papiol S., Grube S. et al. Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin – releasing factor system. Arch Gen Psychiatry. 2011;68(12):1247–1256. https://doi.org/10.1001/archgenpsychiatry.2011.100.</mixed-citation><mixed-citation xml:lang="en">Ribbe K., Ackermann V., Schwitulla J., Begemann M., Papiol S., Grube S. et al. Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin – releasing factor system. Arch Gen Psychiatry. 2011;68(12):1247–1256. https://doi.org/10.1001/archgenpsychiatry.2011.100.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Waldo M.C., Carey G., Myles-Worsley M., Cawthra E., Adler L.E., Nagamoto H.T. et al. Codistribution of asensory gating defi cit and schizophrenia in multiaffected families. Psychiatry Res. 1991;39(3):257–268. https://doi.org/10.1016/0165-1781(91)90092-4.</mixed-citation><mixed-citation xml:lang="en">Waldo M.C., Carey G., Myles-Worsley M., Cawthra E., Adler L.E., Nagamoto H.T. et al. Codistribution of asensory gating deficit and schizophrenia in multi-affected families. Psychiatry Res. 1991;39(3):257–268. https://doi.org/10.1016/0165-1781(91)90092-4.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Corrigan P.W. The Social Perceptual Deficit of Schizophrenia. Psychiatry. 1997;60(4):309–325. https://doi.org/10.1080/00332747.1997.11024809.</mixed-citation><mixed-citation xml:lang="en">Corrigan P.W. The Social Perceptual Deficit of Schizophrenia. Psychiatry. 1997;60(4):309–325. https://doi.org/10.1080/00332747.1997.11024809.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Donohoe G., Robertson I.H. Can specific defi cits in executive functioning explain the negative symptoms of schizophrenia? A review. 2003;9(2):97–108. https://doi.org/10.1076/neur.9.2.97.15075.</mixed-citation><mixed-citation xml:lang="en">Donohoe G., Robertson I.H. Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review. 2003;9(2): 97–108. https://doi.org/10.1076/neur.9.2.97.15075.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Green M.F. Whаt are the functional consequences of neurocognitive deficit in schizophrenia? Am J Psychiatry. 1996;153(3):321–330. https://doi.org/10.1176/ajp.153.3.321.</mixed-citation><mixed-citation xml:lang="en">Green M.F. Whаt are the functional consequences of neurocognitive deficit in schizophrenia? Am J Psychiatry. 1996;153(3):321–330. https://doi.org/10.1176/ajp.153.3.321.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Allen D.N., Goldstein G., Aldarondo F. Neurocognitive dysfunction in patients diagnosed with schizophrenia and alcoholism. Neuropsychology. 1999;13(1):62–68. https://doi.org/10.1037//0894-4105.13.1.62.</mixed-citation><mixed-citation xml:lang="en">Allen D.N., Goldstein G., Aldarondo F. Neurocognitive dysfunction in patients diagnosed with schizophrenia and alcoholism. Neuropsychology. 1999;13(1):62–68. https://doi.org/10.1037//0894-4105.13.1.62.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Goldstein G., Allen D.N., Sanders R.D. Sensory-perceptual dysfunction in patients with schizophrenia and comorbid alcoholism. J Clin Exp Neuropsychol. 2002;24(8):1010–1016. https://doi.org/10.1076/jcen.24.8.1010.8378.</mixed-citation><mixed-citation xml:lang="en">Goldstein G., Allen D.N., Sanders R.D. Sensory-perceptual dysfunction in patients with schizophrenia and comorbid alcoholism. J Clin Exp Neuropsychol. 2002;24(8):1010–1016. https://doi.org/10.1076/jcen.24.8.1010.8378.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Manning V., Betteridge S., Wanigaratne S., Best D., Strang J., Gossop M. Cognitive impairment in dual diagnosis in-patients with schizophrenia and alcohol use disorder. Schizophr Res. 2009;114(l–3):98–104. https://doi.org/10.1016/j.schres.2009.05.020.</mixed-citation><mixed-citation xml:lang="en">Manning V., Betteridge S., Wanigaratne S., Best D., Strang J., Gossop M. Cognitive impairment in dual diagnosis in-patients with schizophrenia and alcohol use disorder. Schizophr Res. 2009;114(l–3):98–104. https://doi.org/10.1016/j.schres.2009.05.020.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Joyal C.C., Haller P., Lapierre D., Hodgins S. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophr Res. 2003;63(3):297–299. https://doi.org/10.1016/S0920-9964(02)00387-0.</mixed-citation><mixed-citation xml:lang="en">Joyal C.C., Haller P., Lapierre D., Hodgins S. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophr Res. 2003;63(3):297–299. https://doi.org/10.1016/S0920-9964(02)00387-0.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Potvin S., Stip E., Roy J.-Y. Schizophrenia and addiction: an evaluation of the self-medication hypothesis. Encephale. 2003;29(3 Pt):193–203. Available at: https://pubmed.ncbi.nlm.nih.gov/12876543/.</mixed-citation><mixed-citation xml:lang="en">Potvin S., Stip E., Roy J.-Y. Schizophrenia and addiction: an evaluation of the self-medication hypothesis. Encephale. 2003;29(3 Pt):193–203. Available at: https://pubmed.ncbi.nlm.nih.gov/12876543/.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В. (ред.). Алгоритмы специализированной медицинской помощи больным сахарным диабетом (6-й выпуск). Сахарный диабет. 2013;(15):1–120. Режим доступа: https://cyberleninka.ru/article/n/algoritmy-spetsializirovannoy-meditsinskoy-pomoschi-bolnymsaharnym-diabetom-pod-redaktsiey-i-i-dedova-m-v-shestakovoy-6-y-vypusk.</mixed-citation><mixed-citation xml:lang="en">Dedov I.I., Shestakova M.V. (eds.). Algorithms of specialized medical care for patients with diabetes mellitus (6th ed.). Sakharnyy diabet = Diabetes Mellitus. 2013;(15):1–120. (In Russ.) Available at: https://cyberleninka.ru/article/n/algoritmy-spetsializirovannoy-meditsinskoy-pomoschi-bolnym-saharnym-diabetom-pod-redaktsiey-i-i-dedova-m-v-shestakovoy-6-y-vypusk.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Гацких И.В., Веселова О.Ф., Брикман И.Н., Шалда Т.П., Адамян Р.А., Петрова М.М. Когнитивные нарушения при сахарном диабете 2 типа. Современные проблемы науки и образования. 2015;(4). Режим доступа: http://www.science-education.ru/ru/article/view?id=20805.</mixed-citation><mixed-citation xml:lang="en">Гацких И.В., Веселова О.Ф., Брикман И.Н., Шалда Т.П., Adamyan R.A., Petrova M.M. Cognitive impairment in type 2 diabetes mellitus. Sovremennye problemy nauki i obrazovaniya = Modern Problems of Science and Education. 2015;(4). (In Russ.) Available at: http://www.science-education.ru/ru/article/view?id=20805.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Петрова М.М., Прокопенко С.В., Пронина Е.А. Когнитивные и эмоциональные нарушения у пациентов с сахарным диабетом 2 типа. Сибирское медицинское обозрение. 2008;(4):83–85. Режим доступа: https://cyberleninka.ru/article/n/kognitivnye-i-emotsionalnye-narusheniya-u-patsientov-saharnym-diabetom-2-tipa.</mixed-citation><mixed-citation xml:lang="en">Petrova M.M., Prokopenko S.V., Pronina E.A. Cognitive and emotional disorders in patients with type 2 diabetes mellitus. Sibirskoe meditsinskoe obozrenie = Siberian Medical Review. 2008;(4):83–85. (In Russ.) Available at: https://cyberleninka.ru/article/n/kognitivnye-i-emotsionalnye-narusheniya-u-patsientov-saharnym-diabetom-2-tipa.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Товажнянская Е.Л., Безуглова И.О., Наврузов М.Б., Балковая Н.С. Умеренные когнитивные нарушения при сахарном диабете 2-го типа. Международный медицинский журнал. 2012;(1):6–9. Режим доступа: http://dspace.nbuv.gov.ua/bitstream/handle/123456789/53303/01-Tovazhnianskaya.pdf?sequence=1.</mixed-citation><mixed-citation xml:lang="en">Tovazhnyanskaya E.L., Bezuglova I.O., Navruzov M.B., Balkovaya N.S. Moderate cognitive impairment in type 2 diabetes mellitus. Mezhdunarodnyy meditsinskiy zhurnal = International Medical Journal. 2012;(1):6–9. (In Russ.) Available at: http://dspace.nbuv.gov.ua/bitstream/handle/123456789/53303/01-Tovazhnianskaya.pdf?sequence=1.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Чугунов П.А., Семенова И.В., Орлов Ю.Ю., Шестакова М.В. Сахарный диабет 2 типа и когнитивные нарушения. Сахарный диабет. 2008;(1):61–66. Режим доступа: https://cyberleninka.ru/article/n/saharnyy-diabet-2-tipa-i-kognitivnye-narusheniya.</mixed-citation><mixed-citation xml:lang="en">Chugunov P.A., Semenova I.V., Orlov Yu.Yu., Shestakova M.V. Type 2 diabetes mellitus and cognitive impairment. Sakharnyy diabet = Diabetes Mellitus. 2008;(1):61–66. (In Russ.) Available at: https://cyberleninka.ru/article/n/saharnyy-diabet-2-tipa-i-kognitivnye-narusheniya.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Mijnhout G.S., Scheltens P., Diamant M., Biessels G.J., Wessels A.M., Simsek S. et al. Diabetic encephalopathy: a concept in need of a definition. Diabetologia. 2006;49(6):1447–1448. https://doi.org/10.1007/s00125-006-0221-8.</mixed-citation><mixed-citation xml:lang="en">Mijnhout G.S., Scheltens P., Diamant M., Biessels G.J., Wessels A.M., Simsek S. et al. Diabetic encephalopathy: a concept in need of a definition. Diabetologia. 2006;49(6):1447–1448. https://doi.org/10.1007/s00125-006-0221-8.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Wild S. Global prevalence of diabetes. Diabetes Care. 2004;27(5):1047–1053. https://doi.org/10.2337/diacare.27.5.1047.</mixed-citation><mixed-citation xml:lang="en">Wild S. Global prevalence of diabetes. Diabetes Care. 2004;27(5):1047–1053. https://doi.org/10.2337/diacare.27.5.1047.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2012;35(1 Suppl.):S11–S63. https://doi.org/10.2337/dc12-s011.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2012;35(1 Suppl.):S11–S63. https://doi.org/10.2337/dc12-s011.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Cosway R., Strachan M.V., Dougall A., Frier B.M., Deary I.J. Cognitive function and information processing in type 2 diabetes. Diabetic Med. 2011;18(10):803–810. https://doi.org/10.1046/j.1464-5491.2001.00577.x.</mixed-citation><mixed-citation xml:lang="en">Cosway R., Strachan M.V., Dougall A., Frier B.M., Deary I.J. Cognitive function and information processing in type 2 diabetes. Diabetic Med. 2011;18(10):803–810. https://doi.org/10.1046/j.1464-5491.2001.00577.x.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Yaffe K., Falvey Ch., Hamilton N., Schwartz A.V., Simonsick E.M., Satterfield S. et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012;69(9):1170–1175. https://doi.org/10.1001/archneurol.2012.1117.</mixed-citation><mixed-citation xml:lang="en">Yaffe K., Falvey Ch., Hamilton N., Schwartz A.V., Simonsick E.M., Satterfield S. et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012;69(9):1170–1175. https://doi.org/10.1001/archneurol.2012.1117.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Nooyens A., Baan C.A., Spijkerman A.M.W., Verschuren W.M.M. Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study. Diabetes Care. 2010;33(9):1964–1969. https://doi.org/10.2337/dc09-2038.</mixed-citation><mixed-citation xml:lang="en">Nooyens A., Baan C.A., Spijkerman A.M.W., Verschuren W.M.M. Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study. Diabetes Care. 2010;33(9):1964–1969. https://doi.org/10.2337/dc09-2038.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Sastre A., Vernooij R.W.M., Harmand M.G.-C., Martínez G. Effect of treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev. 2017;6(6):CD003804. https://doi.org/10.1002/14651858.CD003804.pub2.</mixed-citation><mixed-citation xml:lang="en">Sastre A., Vernooij R.W.M., Harmand M.G.-C., Martínez G. Effect of treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev. 2017;6(6):CD003804. https://doi.org/10.1002/14651858.CD003804.pub2.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell A.J., Vancampfort D., Sweers K., van Winkel R., Yu W., De Hert M. Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders – a Systematic Review and Meta-Analysis. Schizophr Bull. 2013;39(2):306–318. https://doi.org/10.1093/schbul/sbr148.</mixed-citation><mixed-citation xml:lang="en">Mitchell A.J., Vancampfort D., Sweers K., van Winkel R., Yu W., De Hert M. Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders – a Systematic Review and Meta-Analysis. Schizophr Bull. 2013;39(2):306–318. https://doi.org/10.1093/schbul/sbr148.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Горобец Л.Н. Нейроэндокринные дисфункции у больных шизофренией. Социальная клиническая психиатрия. 2005;15(1):89–99. Режим доступа: https://cyberleninka.ru/article/n/neyroendokrinnye-disfunktsii-u-bolnyh-shizofreniey.</mixed-citation><mixed-citation xml:lang="en">Gorobets L.N. Neuroendocrine dysfunctions in patients with schizophrenia. Sotsialnaya klinicheskaya psikhiatriya = Social Clinical Psychiatry. 2005;15(1):89–99. (In Russ.) Available at: https://cyberleninka.ru/article/n/neyroendokrinnye-disfunktsii-u-bolnyh-shizofreniey.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Коркина М.В., Елфимова Е.В. Диабет и когнитивное старение. Журнал неврологии и психиатрии имени С.С. Корсакова. 2004;(3):80–84. Режим доступа: http://elib.fesmu.ru/elib/Article.aspx?id=107449.</mixed-citation><mixed-citation xml:lang="en">Korkina M.V., Elfimova E.V. Diabetes and cognitive aging. Zhurnal nevrolologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2004;(3):80–84. (In Russ.) Available at: http://elib.fesmu.ru/elib/Article.aspx?id=107449.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Мосолов С.Н., Кабанов С.О. Метаболические нарушения при антипсихотической терапии. Социальная и клиническая психиатрия. 2003;13(2):162–171. Режим доступа: https://elibrary.ru/contents.asp?id=33840924.</mixed-citation><mixed-citation xml:lang="en">Mosolov S.N., Kabanov S.O. Metabolic disorders in antipsychotic therapy. Sotsialnaya i klinicheskaya psikhiatriya = Social and Clinical Psychiatry. 2003;13(2):162–171. (In Russ.) Available at: https://elibrary.ru/contents.asp?id=33840924.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Малков К.Д. Особенности динамики непрерывно текущей параноидной шизофрении, сочетанной с алкоголизмом. Вопросы наркологии. 2000;(3):44–50.</mixed-citation><mixed-citation xml:lang="en">Malkov K.D. Features of the dynamics of continuously ongoing paranoid schizophrenia combined with alcoholism. Voprosy narkologii = Addiction Issues. 2000;(3):44–50. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Koller E.A., Doraiswamy P.M. Olanzapine-associated diabetes mellitus. Pharmacotherapy. 2002;22(7):841–852. https://doi.org/10.1592/phco.22.11.841.33629.</mixed-citation><mixed-citation xml:lang="en">Koller E.A., Doraiswamy P.M. Olanzapine-associated diabetes mellitus. Pharmacotherapy. 2002;22(7):841–852. https://doi.org/10.1592/phco.22.11.841.33629.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Sernyak M.J., Leslie D.L., Alarcon R.D., Losonczy M.F., Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry. 2002;159(4):561–566. https://doi.org/10.1176/appi.ajp.159.4.561.</mixed-citation><mixed-citation xml:lang="en">Sernyak M.J., Leslie D.L., Alarcon R.D., Losonczy M.F., Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry. 2002;159(4):561–566. https://doi.org/10.1176/appi.ajp.159.4.561.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Hanssens L., van Winkel R., Wampers M., Van Eyck D., Scheen A., Reginster J.-Y. et al. A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schzoaffective disorder. Schizophr Res. 2008;106(2–3): 308–314. https://doi.org/10.1016/j.schres.2008.09.008.</mixed-citation><mixed-citation xml:lang="en">Hanssens L., van Winkel R., Wampers M., Van Eyck D., Scheen A., Reginster J.-Y. et al. A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schzoaffective disorder. Schizophr Res. 2008;106(2–3): 308–314. https://doi.org/10.1016/j.schres.2008.09.008.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Nasrallah H.A. Atypical antipsychotic-induced metabolic side effects insights from receptor-binding profiles. Mol Psychiatry. 2008;13(1):27–35. https://doi.org/10.1038/sj.mp.4002066.</mixed-citation><mixed-citation xml:lang="en">Nasrallah H.A. Atypical antipsychotic-induced metabolic side effects insights from receptor-binding profiles. Mol Psychiatry. 2008;13(1):27–35. https://doi.org/10.1038/sj.mp.4002066.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Starrenburg F.C.J., Bogers J.P.A.M. How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. Eur Psychiatry. 2009;24(3):164–170. https://doi.org/10.1016/j.eurpsy.2009.01.001.</mixed-citation><mixed-citation xml:lang="en">Starrenburg F.C.J., Bogers J.P.A.M. How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. Eur Psychiatry. 2009;24(3):164–170. https://doi.org/10.1016/j.eurpsy.2009.01.001.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Fenton W.S., Chavez M.R. Medication-Induced Weight Gain and Dyslipidemia in Patients with Schizophrenia. Am J Psychiatry. 2006;163(10):1697–1704. https://doi.org/10.1176/ajp.2006.163.10.1697.</mixed-citation><mixed-citation xml:lang="en">Fenton W.S., Chavez M.R. Medication-Induced Weight Gain and Dyslipidemia in Patients with Schizophrenia. Am J Psychiatry. 2006;163(10):1697–1704. https://doi.org/10.1176/ajp.2006.163.10.1697.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Van Winkel R., de Hert M., Wampers M., Van Eyck D., Hanssens L., Scheen A., Peuskens J. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry. 2008;69(3):472–479. https://doi.org/10.4088/jcp.v69n0320.</mixed-citation><mixed-citation xml:lang="en">Van Winkel R., de Hert M., Wampers M., Van Eyck D., Hanssens L., Scheen A., Peuskens J. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry. 2008;69(3):472–479. https://doi.org/10.4088/jcp.v69n0320.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Thonnard-Neumann E. Phenothiazines and diabetes in hospitalized women. Am J Psychiatry. 1968;124(7):978–982. https://doi.org/10.1176/ajp.124.7.978.</mixed-citation><mixed-citation xml:lang="en">Thonnard-Neumann E. Phenothiazines and diabetes in hospitalized women. Am J Psychiatry. 1968;124(7):978–982. https://doi.org/10.1176/ajp.124.7.978.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Marinov A. Diabetes in chronic schizophrenia. Dis Nerv Syst. 1971;32(11): 777–778. Available at: https://pubmed.ncbi.nlm.nih.gov/5131772/.</mixed-citation><mixed-citation xml:lang="en">Marinov A. Diabetes in chronic schizophrenia. Dis Nerv Syst. 1971;32(11): 777–778. Available at: https://pubmed.ncbi.nlm.nih.gov/5131772/.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Двирский А. А. Взаимное модифицирующее влияние шизофрении и сахарного диабета на их фенотипические проявления. Цитология и генетика. 1997;(5):73–76.</mixed-citation><mixed-citation xml:lang="en">Dvirsky A.A. Mutual modifying effect of schizophrenia and diabetes mellitus on their phenotypic manifestations. Citologiya I genetika = Cytology and Genetics. 1997;(5):73–76. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Выборных Д.Е. Психические нарушения при сахарном диабете. Медицинская помощь. 1994;(5):35–37. Режим доступа: https://istina.msu.ru/publications/article/18566835/.</mixed-citation><mixed-citation xml:lang="en">Vybornykh D.E. Mental disorders in diabetes mellitus. Meditsinskaya pomoshch = Health Сare. 1994;(5):35–37. (In Russ.) Available at: https://istina.msu.ru/publications/article/18566835.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Шулькин Л.М. Особенности формирования и течения алкогольной зависимости у пациентов с параноидной шизофренией. Вопросы наркологии. 2008;(6):5–11. Режим доступа: https://elibrary.ru/maintenance.asp.</mixed-citation><mixed-citation xml:lang="en">Shulkin L.M. Features of the formation and course of alcohol dependence in patients with paranoid schizophrenia. Voprosy narkologii = Addiction Issues. 2008;(6):5–11. (In Russ.) Available at: https://elibrary.ru/maintenance.asp.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Johnstone E.C., Ebmeier K.P., Miller P., Owens D.G.C., Lawrie S.M. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry. 2005;186:18–25. https://doi.org/10.1192/bjp.186.1.18.</mixed-citation><mixed-citation xml:lang="en">Johnstone E.C., Ebmeier K.P., Miller P., Owens D.G.C., Lawrie S.M. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry. 2005;186:18–25. https://doi.org/10.1192/bjp.186.1.18.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Ribbe K., Ackermann V., Schwitulla J., Begemann M., Papiol S., Grube S. et al. Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Arch Gen Psychiatry. 2011;68(12):1247–1256. https://doi.org/10.1001/archgenpsychiatry.2011.100.</mixed-citation><mixed-citation xml:lang="en">Ribbe K., Ackermann V., Schwitulla J., Begemann M., Papiol S., Grube S. et al. Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Arch Gen Psychiatry. 2011;68(12):1247–1256. https://doi.org/10.1001/archgenpsychiatry.2011.100.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Sternberg R.J., Detterman D.K. (eds.). What is intelligence? Contemporary viewpoints on its nature and definition. New Jersey: Ablex; 1986.</mixed-citation><mixed-citation xml:lang="en">Sternberg R.J., Detterman D.K. (eds.). What is intelligence? Contemporary viewpoints on its nature and definition. New Jersey: Ablex; 1986.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Анастази А., Урбина С. Психологическое тестирование. 7-е изд. СПб.: Питер-Пресс; 2007. 688 с. Режим доступа: https://bookree.org/reader?file=771340.</mixed-citation><mixed-citation xml:lang="en">Anastasi A., Urbina S. Psychological testing. 7th ed. New Jersey: Prentice Hall; 1997. 721 p.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Rimmer J.H., Yamaki K., Lowry B.M., Wang E., Vogel L.C. Obesity and obesity-related secondary conditions in adolescents with intellectual/ developmental disabilities. J Intellect Disabil Res. 2010;54(9):787–794. https://doi.org/10.1111/j.1365-2788.2010.01305.x.</mixed-citation><mixed-citation xml:lang="en">Rimmer J.H., Yamaki K., Lowry B.M., Wang E., Vogel L.C. Obesity and obesity-related secondary conditions in adolescents with intellectual/ developmental disabilities. J Intellect Disabil Res. 2010;54(9):787–794. https://doi.org/10.1111/j.1365-2788.2010.01305.x.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">de Winter C.F., Magilsen K.W., van Alfen J.C., Penning C., Evenhuis H.M. Prevalence of cardiovascular risk factors in older people with intellectual disability. Am J Intellect Dev Disabil. 2009;114(6):427–436. https://doi.org/10.1352/1944-7558-114.6.427.</mixed-citation><mixed-citation xml:lang="en">de Winter C.F., Magilsen K.W., van Alfen J.C., Penning C., Evenhuis H.M. Prevalence of cardiovascular risk factors in older people with intellectual disability. Am J Intellect Dev Disabil. 2009;114(6):427–436. https://doi.org/10.1352/1944-7558-114.6.427.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Deary I.J., Crawford J.R., Hepburn D.A., Langan S.J., Blackmore L.M., Frier B.M. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes. 1993;42(2):341–344. https://doi.org/10.1136/bmj.313.7060.767.</mixed-citation><mixed-citation xml:lang="en">Deary I.J., Crawford J.R., Hepburn D.A., Langan S.J., Blackmore L.M., Frier B.M. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes. 1993;42(2):341–344. https://doi.org/10.1136/bmj.313.7060.767.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Волчегорский И.А., Местер Н.В., Зотова О.Г. Предикторы диабетической энцефалопатии. Журнал неврологии и психиатрии имени С.С. Корсакова. 2006;106(9):12–16.</mixed-citation><mixed-citation xml:lang="en">Volchegorsky I.A., Mester N.V., Zotova O.G. Predictors of diabetic encephalopathy. Zhurnal nevrolologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2006;106(9):12–16. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Анохина И.П. Биологические механизмы зависимости от психоактивных веществ (патогенез). В: Иванец Н.Н. Лекции по наркологии. 2-е изд. М.: Нолидж; 2000. 448 с. Режим доступа: https://zakon.today/narkologiya_1008/biologicheskie-mehanizmyi-zavisimosti-89225.html.</mixed-citation><mixed-citation xml:lang="en">Anokhina I.P. Biological mechanisms of dependence on psychoactive substances (pathogenesis). В: Ivanets N.N. Lectures on narcology. 2nd ed. Moscow: Nolidzh; 2000. 448 p. (In Russ.) Available at: https://zakon.today/narkologiya_1008/biologicheskie-mehanizmyi-zavisimosti-89225.html.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Блейхер В.М., Крук И.В., Боков С.Н. Клиническая патопсихология. М.: Издательство Московского психолого-социального института; Воронеж: МОДЭК; 2002. 512 с. Режим доступа: https://bookree.org/reader?file=553962.</mixed-citation><mixed-citation xml:lang="en">Bleicher V.M., Kruk I.V., Bokov S.N. Clinical pathopsychology. Moscow: Publishing Office of Moscow Psychological and Social Institute; Voronezh; MODEK; 2002. 512 p. (In Russ.) Available at: https://bookree.org/reader?file=553962.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Кирпиченко А.А. О следовых явлениях у больных шизофренией. Журнал невропатологии и психиатрии. 1966;(11):1672–1676.</mixed-citation><mixed-citation xml:lang="en">Kirpichenko A.A. On trace phenomena in patients with schizophrenia. Zhurnal nevropatologii i psikhiatrii = Journal of Neuropathology and Psychiatry. 1966;(11):1672–1676. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Barnett A.H., Mackin P., Chaudhry I., Farooqi A., Gadsby R., Heald A. et al. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidemia. J Psychopharmacol. 2007;21(4):357–373. https://doi.org/10.1177/0269881107075509.</mixed-citation><mixed-citation xml:lang="en">Barnett A.H., Mackin P., Chaudhry I., Farooqi A., Gadsby R., Heald A. et al. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidemia. J Psychopharmacol. 2007;21(4):357–373. https://doi.org/10.1177/0269881107075509.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Liao C.H., Chang C.S., Wei W.C., Chang S.-N., Liao C.-C., Lane H.-Y., Sung F.-C. Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: a population-based study. Schizophr Res. 2011;126(1–3):110–116. https://doi.org/10.1016/j.schres.2010.12.007.</mixed-citation><mixed-citation xml:lang="en">Liao C.H., Chang C.S., Wei W.C., Chang S.-N., Liao C.-C., Lane H.-Y., Sung F.-C. Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: a population-based study. Schizophr Res. 2011;126(1–3):110–116. https://doi.org/10.1016/j.schres.2010.12.007.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Dixon L., Weiden P., Delahanty J., Goldberg R., Postrado R., Lucksted A., Lehman A. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull. 2000;26(4):903–912. https://doi.org/10.1093/oxfordjournals.schbul.a033504.</mixed-citation><mixed-citation xml:lang="en">Dixon L., Weiden P., Delahanty J., Goldberg R., Postrado R., Lucksted A., Lehman A. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull. 2000;26(4):903–912. https://doi.org/10.1093/oxfordjournals.schbul.a033504.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Cimo A., Stergiopoulos E., Cheng C., Bonato S., Dewa C.S. Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review. BMC Psychiatry. 2012;12:24. https://doi.org/10.1186/1471-244X-12-24.</mixed-citation><mixed-citation xml:lang="en">Cimo A., Stergiopoulos E., Cheng C., Bonato S., Dewa C.S. Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review. BMC Psychiatry. 2012;12:24. https://doi.org/10.1186/1471-244X-12-24.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
